Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lenalid® Tab - Oncology Injection - Pharmaceuticals - Product Samyang Biopharmaceuticals
Connect with this vendor - Learn about this product

Lenalid® Tab

Lenalid® Tab Lenalidomide/Tab 2.5mg, 5mg, 7.5mg, 10mg, 15mg, 20mg, 25mg Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS), Mantle Cell Lymphoma (MCL) Increased Patient Compliance Completion of BE Studies Guaranteed Safety of Drug Product

Specialty: